McKesson Corporation (MCK) Stock Price Today
Aura AI Summary
Key Stats
- $104.54BMarket Cap
- -Volume
- HealthSector
- $995.6952W High
- $681.0252W Low
- -Typical Hold Time
- $111.08BEnterprise Value
- 0.42%Div Yield
- -Trading Activity
Track McKesson Corporation (MCK) stock price today on Pluang, updated in real time with live charts and market data. Over the past 52 weeks, McKesson Corporation has traded between a low of $681.02 and a high of $995.69, highlighting its annual price range. Buy and sell McKesson Corporation shares on Pluang with fractional shares and real-time market data — safe and OJK-regulated.
About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Most Recent News
Meta's $18B legal settlement costs $1B/year, minimal impact on revenue and growth potential.
Meta has agreed to an $18 billion legal settlement, which translates to about $1 billion per year—an amount negligible compared to its substantial revenue and earnings. The settlement resolves regulatory uncertainties, allowing Meta to focus on its c...

US-Iran conflict settles into prolonged standoff with economic pressure as main US strategy.
Six months after the US and Israel launched combat operations in Iran, the conflict remains a stalemate with no clear resolution. The Trump administration has shifted from military action to economic pressure, including secondary sanctions, aiming to...

OpenAI launches ads on ChatGPT in India to boost revenue before 2027 IPO
OpenAI has introduced advertisements on ChatGPT for free users and those on its low-cost 'Go' plan in India, one of its largest markets. This move aims to increase revenue ahead of its planned 2027 public listing and support broader access through fr...

People also bought
Frequently Asked Questions
All investments involve risks and the possibility of a loss in investment value. Past performance is not indicative of future results. Historical performance, expected returns, and probability projections are provided for informational and illustrative purposes only.